Vision Care

AM Best Withdraws Credit Ratings of Vision Service Plan and Its Subsidiaries - Business Wire [Visit Site | Read More]

OKYO's urcosimod gets FDA nod, moves to global phase 3 trial for NCP - Eyes On Eyecare [Visit Site | Read More]